RBC Capital Reiterates Outperform on QuidelOrtho, Maintains $136 Price Target
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Conor McNamara has reiterated an Outperform rating on QuidelOrtho (NASDAQ:QDEL) and maintained a price target of $136.
August 09, 2023 | 3:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital's reiteration of an Outperform rating and maintenance of a $136 price target on QuidelOrtho could positively influence the company's stock in the short term.
Analyst ratings and price targets can significantly influence a company's stock price. In this case, RBC Capital's reiteration of an Outperform rating and maintenance of a $136 price target for QuidelOrtho indicates a positive outlook for the company, which could lead to an increase in its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100